Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients

Thrombosis Research

Volumn 90, Issue 4, 1998, Pages 181-190

  Knobler, Hilla ^a   Savion, Naphtali ^d   Shenkman, Boris ^b   Kotev Emeth, Shlomo ^d   Varon, David ^b,c  

^a KAPLAN HOSPITAL   (Israel)

^b The Amalia Biron Research Institute of Thrombosis and Hemostasis   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d NONE

Author keywords

Diabetes mellitus; Platelet activation; Platelet adhesion; Platelets aggregation

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EXTRACELLULAR MATRIX; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SHEAR STRESS; SUBENDOTHELIUM; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ADULT; AGED; ARTERIOSCLEROSIS; BLOOD PLATELETS; CELL ADHESION; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; HEMATOCRIT; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; STRESS, MECHANICAL; TIME FACTORS; TRIGLYCERIDES;

EID: 0032524379     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00050-4     Document Type: Article

References (41)

1. 1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-45.
2. 2. Tschoepe D, Roesen P, Schwippert B, Gries FA. Platelets in diabetes: The role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost 1993;19:122-8.
3. 3. Winocour PD. Platelet abnormalities in diabetes mellitus. Diabetes 1992;41(Suppl II):26-31.
4. 4. Fuster V, Badimon JJ, Chesebro JH. The pathogenesis of coronary disease and the acute coronary syndrome. N Eng J Med 1992;326: 242-50.
5. 5. Elwood PC, Renaud S, Sharp DS, Beswick AD, O'Brian JR, Yarnell JWG. Ischemic heart disease and platelet aggregation: The Caerphilly collaborative heart disease study. Circulation 1991;83:38-44.
6. 6. Trip MD, Cats VM, van Capelle FJL, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Eng J Med 1990;322:1549-54.
7. 7. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet. I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.
8. 8. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin, and hyperplasia in restenosis after coronary angiography. J Am Coll Cardiol 1991; 17:77B-88B.
9. 9. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Eng J Med 1994;330:956-61.
10. 10. Weintraub WS, Kosinski AS, Brown CL, King SB. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993;21:6-14.
11. 11. Carrozza JP, Kuntz R, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 1993;118:344-9.
12. 12. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996;27: 528-35.
13. 13. Sagel J, Colwell JA, Crook L, Laimins M. Increased platelet aggregation in diabetes mellitus. Ann Intern Med 1975;83:733-8.
14. 14. Colwell, JA, Halushka PV. Platelet function in diabetes mellitus. Br J Haematol 1980;44: 521-6.
15. 15. Kwaan HC, Collwell JA, Cruz S, Suwanwele N, Dobbie JG. Increased platelet aggregation in diabetes mellitus. J Lab Clin Med 1972;20: 235-46.
16. 16. Alessandrini P, McRae J, Feman S, FitzGerald GA. Thromboxane biosynthesis and platelet function in type I diabetes mellitus. N Eng J Med 1988;319:208-12.
17. 17. Gray RP, Hendra TJ, Pattarson DLH, Yudkin JS. "Spontaneous" platelet aggregation in whole blood in diabetic and nondiabetic survivors of acute myocardial infarction. Thromb Haemost 1993;70:932-6.
18. 18. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL. Platelet and shear stress. Blood 1996;88:1525-41.
19. 19. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17:1281-9.
20. 20. Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997;85:283-94.
21. 21. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. 22. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991;87:1234-40.
23. 23. Remaley AT, Kennedy JA, Laposata ML. Evalnation of the clinical utility of platelet aggregation studies. Am J Hematol 1989; 31:188-93.
24. 24. Colwell JA, Winocour PD, Halushka PV. Do platelets have anything to do with diabetic microvascular disease? Diabetes 1983;32(Suppl II):14-9.
25. 25. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes 1995;44:890-4.
26. 26. Juhan I, Buonocure M, Jouve R, Vague PH, Moulin JP, Vialttes B. Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1982;1:535-7.
27. 27. Surya II, Akkerman JWN. The influence of lipoproteins on blood platelets. Am Heart J 1993;125:272-5.
28. 28. Brook JB, Aviram M. Platelet lipoprotein interactions. Semin Thromb Hemost 1988;14: 258-65.
29. 29. Hochgraf E, Levy Y, Aviram M, Brook JG, Cogan U. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. Metabolism 1994;43: 11-7.
30. 30. Steele P, Rainwater J. Effect of dietary and pharmacologic alteration of serum lipids on platelet survival time. Circulation 1978;58: 365-7.
31. 31. Yosefy C, Viskoper JR, Varon D, Ilan Z, Pilpel D, Lugassy G, Schneider R, Savyon N, Adan Y, Raz A. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): A novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis. J Hum Hypertens 1996;10 (Suppl III):S135-S9.
32. 32. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.
33. 33. Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Warns B. The Eurodiab IDDM Complication Study Group. Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care 1996; 19:689-97.
34. 34. ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus: Early treatment diabetic retinopathy study report 14. JAMA 1992;268:1292-300.
35. 35. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin both or neither among 17,187 cases of suspected acute myocardial infarctions: ISIS-2. Lancet 1988;2:349-60.
36. 36. Szczeklik A, Musial J, Undas A, Swadzba J, Gora P, Duplaga M. Aspirin inhibits the thrombinogenesis in normocholesterolemic but not in hypercholesterolemic man. Thromb Haemost 1993;69:798.
37. 37. Collier A, Watson HH, Patrick AW, Ludlam CA, Clarke BF. Effect of glycemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetes Metab 1989;15:420-5.
38. 38. Islim IF, Beevers DG, Bareford D. The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension. J Hypertens 1992;10:379-83.
39. 39. Knight CJ, Panesar M, Wilson DJ, Chronos NA, Patel D, Fox K, Goodall AH. Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina. Circulation 1997;95:125-32.
40. 40. Gasser JA, Betterridge DJ. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers. J Cardiovasc Pharmacol 1991;18 (Suppl IV): S29-S34.
41. 41. Jimenez AH, Stubbs ME, Tofler GH, Winter K, Williams GH, Muller JE. Rapidity and duration of platelet suppression by entric-coated aspirin in healthy young men. Am J Cardiol 1992;69:258-62.